Parecoxib for pain after bleeding stroke study
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests a pain medicine called parecoxib (injected into a vein) for people who have had a bleeding stroke around the brain (subarachnoid hemorrhage). It aims to see if it helps with pain without causing serious side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You weigh more than 110 pounds (50 kg)
- You were diagnosed with a spontaneous bleed around the brain (subarachnoid hemorrhage) within the last 48 hours
- You are not pregnant, breastfeeding, or planning to become pregnant
- You are not taking certain other pain relievers or steroids
- You do not have severe liver disease, active stomach ulcers, or certain heart conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests whether celecoxib (an anti-inflammatory medicine) can improve outcomes after an intracerebral hemorrhage (a type of stroke caused by bleeding in the brain). It also studies how the medicine may help the body recover. You would need to start treatment quickly after symptoms begin and meet several safety and bleeding-control requirements.
This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
This trial compares two forms of the pain reliever parecoxib in healthy volunteers to see if they work the same in the body. It requires participants to be fasting and have no major health issues.
This trial tests two blood-thinning medications (sarpogrelate and clopidogrel) to see which one improves blood flow in the legs better and is safer for people who have had a stroke and also have leg pain when walking due to narrowed arteries.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
Hear when a new Neurological Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.